Trade Groups Back Warner Chilcott In 3rd Circ. Doryx Row
Generic drugmaker Warner Chilcott PLC received ample support from various industry groups and professors Monday in its efforts to persuade the Third Circuit to reject Mylan Pharmaceuticals Inc.'s bid to revive...To view the full article, register now.
Already a subscriber? Click here to view full article